Chemomab Therapeutics Ltd (CMMB)
0.87
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
0.8442
-0.03
(-2.97%)
After-Hours: 20:00
Chemomab Therapeutics Shareholders Equity (Quarterly): 13.33M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.33M |
| June 30, 2023 | 21.99M |
| March 31, 2023 | 27.95M |
| December 31, 2022 | 36.22M |
| September 30, 2022 | 44.62M |
| June 30, 2022 | 51.84M |
| Date | Value |
|---|---|
| March 31, 2022 | 57.24M |
| December 31, 2021 | 61.47M |
| September 30, 2021 | 65.51M |
| June 30, 2021 | 68.04M |
| March 31, 2021 | 55.16M |
| December 31, 2020 | 10.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.80M
Minimum
Dec 2020
68.04M
Maximum
Jun 2021
42.85M
Average
48.23M
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd | 65.56M |
| Pluri Inc | -0.356M |
| BioLine Rx Ltd | 13.22M |
| Can Fite Biofarma Ltd | 6.243M |
| BiomX Inc | 3.081M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.01M |
| Total Liabilities (Quarterly) | 4.678M |